Rhizopogon luteolus and Ganoderma adspersum Extracts Inhibit Invasion through the Crosstalk between Anti-oxidant
Aydın Demiray1, Ege Rıza Karagür1, Gülsen Tel-Cayan2
1Department of Medical Genetic, School of Medicine, Pamukkale University, Denizli, Turkey.
Objective:
Lung cancer is the primary cause of cancer-related deaths globally. Protein kinase B (AKT) protein is associated with many pathways in non-small cell lung cancer (NSCLC), such as proliferation, migration, invasion, and apoptosis. Mushrooms have a long history of being used in traditional medicine to treat various diseases. Scientists have been exploring the potential of mushrooms for their antioxidant and anticancer properties. In our study, the anti-oxidant, invasion, and apoptosis effects of mushroom extracts were investigated in NSCLC.
Materials And Methods:
Non-Small Cell Lung Cancer cell lines H1299, PC-3, and PC-14 were used in our study. After obtaining the extracts of Rhizopogon luteolus and Ganoderma adspersum, IC50 value was calculated as 25.04-11.73-16.54 ng/ul for R. luteolus and 2.97-1.53-1.01 μg/ul for G. adspersum, respectively, in H1299, PC3 and PC14 cell lines. Afterward, proliferative and invasion effects, as well as apoptosis and anti-oxidant effects, were investigated using the IC50 dose. Western blotting was performed to investigate the pathways of these effects.
Results:
According to the results of our study, Rhizopogon luteolus and Ganoderma adspersum extracts have anti-proliferative and anti-invasive effects on non-small lung cancer cell lines and induced apoptosis, which has been found to increase the anti-oxidant effect. It was found that this effect was due to cross-talk between antioxidant activity and the AKT-Rb pathway.
Conclusion:
We anticipate that Rhizopogon luteolus and Ganoderma adspersum extracts will be effective in cancer treatment by suppressing lung cancer cells via p-Akt and Rb.
Insights
Mushroom extracts from Rhizopogon luteolus and Ganoderma adspersum show promise in fighting non-small cell lung cancer. These natural compounds inhibit cancer cell proliferation and invasion while promoting apoptosis, offering a potential new avenue for lung cancer treatment.
Area of Science:
- Oncology
- Pharmacology
- Mycology
Background:
- Lung cancer is a leading cause of cancer mortality worldwide.
- Protein kinase B (AKT) signaling pathways are implicated in non-small cell lung cancer (NSCLC) progression.
- Mushrooms possess known antioxidant and anticancer properties, prompting investigation into their therapeutic potential.
Purpose of the Study:
- To investigate the antioxidant, anti-invasion, and apoptosis-inducing effects of mushroom extracts in NSCLC.
- To explore the underlying molecular mechanisms, including the AKT-Rb pathway.
Main Methods:
- Utilized NSCLC cell lines (H1299, PC-3, PC-14).
- Prepared and applied extracts of *Rhizopogon luteolus* and *Ganoderma adspersum* at calculated IC50 doses.
- Assessed antiproliferative, anti-invasive, antioxidant, and apoptosis-inducing effects.
- Employed Western blotting to analyze relevant signaling pathways.
Main Results:
- Both *R. luteolus* and *G. adspersum* extracts demonstrated significant anti-proliferative and anti-invasive effects on NSCLC cells.
- The mushroom extracts successfully induced apoptosis in cancer cells.
- Enhanced antioxidant activity was observed, linked to the AKT-Rb pathway.
Conclusions:
- *Rhizopogon luteolus* and *Ganoderma adspersum* extracts exhibit potent anticancer properties against NSCLC.
- These extracts suppress lung cancer cell growth and invasion by modulating the p-Akt and Rb pathways.
- Mushroom-derived compounds represent a promising therapeutic strategy for lung cancer treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity
Negative Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation


